163617-85-4

Basic information

• Product Name: N-(1-adamantanecarbonyl)-N'-(4-methoxyphenyl)methyl-1,2-phenylenediamine
• Synonyms: N-(1-adamantanecarbonyl)-N'-(4-methoxyphenyl)methyl-1,2-phenylenediamine
• CAS NO: 163617-85-4
• Molecular Weight: 390.525
• Mol File: 163617-85-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(1-adamantanecarbonyl)-N'-(4-methoxyphenyl)methyl-1,2-phenylenediamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(1-adamantanecarbonyl)-N'-(4-methoxyphenyl)methyl-1,2-phenylenediamine(163617-85-4)
• EPA Substance Registry System: N-(1-adamantanecarbonyl)-N'-(4-methoxyphenyl)methyl-1,2-phenylenediamine(163617-85-4)

Safety Data

• Hazardous Substances Data: 163617-85-4(Hazardous Substances Data)

Upstream product

• 5729-16-8 N-(4-methoxy-benzyl)-benzene-1,2-diamine 
• 2094-72-6 1-Adamantanecarbonyl chloride 

Downstream Products

• 163617-90-1 N-[1-(1-adamantyl)methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-phenylurea 
• 1322055-75-3 N-[1-(1-adamantyl)methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-(4-fluorophenyl)urea 
• 1322055-91-3 N-[1-(1-adamantyl)methyl-5-(2-diethylaminoethyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-phenylurea 
• 1322055-96-8 N-[1-(1-adamantyl)methyl-5-(2-diethylaminoethyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-(4-fluorophenyl)urea 
• 1322056-02-9 N-(1-(1-adamantyl)methyl-2,4-dioxo-5-[2-(morpholin-4-yl)ethyl]-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-N'-(4-fluorophenyl)urea 
• 163617-86-5 N-(1-adamantyl)methyl-N'-(4-methoxyphenyl)methyl-1,2-phenylenediamine 
• 163617-87-6 1-(1-adamantyl)methyl-2,4-dioxo-5-(4-methoxyphenyl)methyl-3-phenylhydrazono-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine 
• 163617-88-7 1-(1-adamantyl)methyl-3-amino-2,4-dioxo-5-(4-methoxyphenyl)methyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine 

Relevant articles and documents

Synthesis and structure-activity relationship of new 1,5-dialkyl-1,5- benzodiazepines as cholecystokinin-2 receptor antagonists

This article deals with the synthesis and the activities of some 1,5-dialkyl-3-arylureido-1,5-benzodiazepin-2,4-diones which were prepared as potential CCK2 antagonists, with the intention to find a possible follow up of our lead compound GV150013, showin